Drug Plastics Executive and Leadership Team

Rick Biesecker, the Chief Executive Officer at Drug Plastics, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the production of specialized packaging for medicinal and wellness products, Biesecker ensures that manufacturing standards meet rigorous industry requirements. This leadership role involves constant collaboration with the board to drive sustainable growth and operational efficiency across all facilities. By prioritizing innovation in plastic manufacturing, the Chief Executive Officer maintains a competitive edge in the healthcare supply chain. Rick Biesecker actively monitors market trends to adjust production capabilities, ensuring that the company remains a reliable partner for global pharmaceutical brands. Through disciplined management of resources and a focus on quality control, Biesecker secures the company's reputation as a leader in the packaging sector, consistently delivering value to stakeholders while navigating the complexities of the modern manufacturing landscape.

Frederick Biesecker, the Founder & Chief Executive Officer at Drug Plastics, architects the foundational principles and high-level strategic direction of the enterprise. Managing the legacy and future trajectory of the company, Biesecker oversees the integration of advanced manufacturing technologies into the core packaging business. This executive role requires deep engagement with industry stakeholders to ensure that the company provides superior solutions for medicinal and lifestyle products. Frederick Biesecker drives the expansion of market reach by fostering a culture of precision and reliability within the organization. By aligning corporate objectives with the evolving needs of the healthcare industry, the Founder & Chief Executive Officer ensures that the business remains at the forefront of plastic packaging innovation. Through consistent oversight of high-level initiatives, Biesecker maintains the integrity of the brand while steering the company toward sustained profitability and operational excellence in a demanding global market.

Timothy Kochen, the Chief Financial Officer at Drug Plastics, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing financial reporting, budgeting, and risk management, Kochen ensures that the company maintains the liquidity necessary to support large-scale manufacturing operations. This leadership role involves close coordination with the executive team to optimize cost structures and improve margins across the medicinal and wellness packaging lines. Timothy Kochen directs the financial planning processes that enable the company to invest in new technologies and facility upgrades. By analyzing economic data and market performance, the Chief Financial Officer provides the insights required to make informed decisions regarding capital expenditures and long-term growth initiatives. Through rigorous oversight of financial controls and compliance, Kochen protects the company's assets and supports the overall mission of delivering high-quality packaging solutions to a diverse and demanding client base.

Lissa Longacre, the President and CAO at Drug Plastics, directs the daily administrative functions and operational execution of the company. Overseeing the integration of internal processes, Longacre ensures that the manufacturing of medicinal and wellness packaging remains seamless and efficient. This leadership role involves coordinating between departments to streamline workflows and improve organizational productivity. Lissa Longacre manages the administrative infrastructure that supports the company's growth, ensuring that all operational policies align with the broader corporate mission. By focusing on process improvement and cross-functional collaboration, the President and CAO drives the company toward higher standards of service and reliability. Longacre monitors key performance indicators to identify areas for optimization, ensuring that the organization remains responsive to the needs of the healthcare market. Through diligent management of administrative and operational tasks, Longacre secures the company's ability to deliver consistent, high-quality packaging solutions to clients across the country.

Thomas Erario, the Chief People Officer & Vice President, Procurement at Drug Plastics, directs the human capital strategy and the complex supply chain operations required for plastic manufacturing. Overseeing talent acquisition, employee development, and the procurement of raw materials, Erario ensures that the company possesses both the workforce and the resources to meet production demands. This dual-function role involves balancing the needs of the workforce with the necessity of maintaining a stable and cost-effective supply of high-grade plastics for medicinal packaging. Thomas Erario architects programs that foster a culture of safety and efficiency, while simultaneously negotiating with global suppliers to secure essential materials. By integrating human resources initiatives with procurement logistics, the Chief People Officer & Vice President, Procurement optimizes operational workflows. Erario ensures that the company remains agile in the face of supply chain fluctuations, ultimately supporting the delivery of critical packaging products to the wellness and lifestyle sectors.